Cargando…
Correction to: In Vivo Modeling of Human Breast Cancer Using Cell Line and Patient-Derived Xenografts
Autores principales: | Souto, Eric P., Dobrolecki, Lacey E., Villanueva, Hugo, Sikora, Andrew G., Lewis, Michael T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9433351/ https://www.ncbi.nlm.nih.gov/pubmed/35881233 http://dx.doi.org/10.1007/s10911-022-09524-8 |
Ejemplares similares
-
In Vivo Modeling of Human Breast Cancer Using Cell Line and Patient-Derived Xenografts
por: Souto, Eric P., et al.
Publicado: (2022) -
Correction: Selective Small Molecule Stat3 Inhibitor Reduces Breast Cancer
Tumor-Initiating Cells and Improves Recurrence Free Survival in a Human-Xenograft
Model
por: Dave, Bhuvanesh, et al.
Publicado: (2012) -
Immunologically “cold” triple negative breast cancers engraft at a higher rate in patient derived xenografts
por: Petrosyan, Varduhi, et al.
Publicado: (2022) -
Correction: Effective drug treatment identified by in vivo screening in a transplantable patient-derived xenograft model of chronic myelomonocytic leukemia
por: Kloos, Arnold, et al.
Publicado: (2021) -
Publisher Correction: A reference collection of patient-derived cell line and xenograft models of proneural, classical and mesenchymal glioblastoma
por: Stringer, Brett W., et al.
Publicado: (2020)